🇺🇸 SECCignaDoubao · 实盘不做把握 9/10不做原因:不是事件
北京时间·🕒 发布 10-10 04:15:23·⟳ 抓取 09:09:43 +1d04h·⚡ 决策 10-11 09:12:10 +2m27s·16.5 天前
信诺集团（Cigna）一名董事将于2026年底正常退休，明确非因与公司分歧
SEC 8-K 仅披露一名董事的正常退休并明确非因分歧，属例行人事/治理事项，对公司未来盈利、现金流、控制权或估值无可确认的增量影响，不构成可交易事件。
📄 原文Cigna↗ 原文
----- ef20083475_8k.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT…
不做 The Cigna Group（CI.US）
仅为一名外部董事按计划于2026年底退休且明确非因分歧，属例行治理备案，无盈利/控制权/资本影响，无预期差与交易 edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Cigna 的 8-K 只报告董事 Donna Zarcone 将于2026年底正常退休，且明确与公司无分歧；这是例行董事更替，无预期差、无基本面冲击，故回避，不做多空。
🔎 新鲜度:最早出现 2026-10-09 · 扩散 low · price-in 风险 low ↗
主要风险
- 单一外部董事退休通常已提前安排且董事会仍正常运作；公告不含任何继任争议、治理冲突或战略变化信号。
反向证据
- 做多前查反向 · 来源 filing · 日期 2026-10-09 · 影响 none
原文仅一项 Item 5.02 且明确‘not the result of any disagreement’，无任何可支持做多或做空的负面/正面增量。
检索:Cigna 8-K 是否同时隐含高管离任、治理冲突、控制权或其他重大事项 原文 ↗
先例如何影响了这次决策
对本次决策的影响:确认直接 AVOID，不产生多空方向或仓位。
方向:不适用：单一外部董事正常退休（无分歧）属例行治理事项，历史上不构成系统性可交易催化，无需以先例校准幅度。
涨幅量级:无任何财务/控制权增量，缺乏可定价的量级，故不设止盈止损、不引用先例。
形态:不适用；未对此非事件检索先例，因任何价格反应样本都无法改变‘无交易 edge’的结论。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 9 ms
{"result": "search_processed_events:agent query=`cigna donna zarcone retirement board of directors | the cigna group 8-k item 5.02 director retirement december 31 2026 | zarcone 退休 cigna 董事`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继
原文全文
展开原文 · 2,737 字
----- ef20083475_8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 6, 2026
The Cigna Group
(Exact name of registrant as specified in its charter)
Delaware
001-38769
82-4991898
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
900 Cottage Grove Road
Bloomfield
,
Connecticut
06002
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(
860
)
226-6000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.01
CI
New York Stock Exchange, Inc.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 6, 2026, Donna F. Zarcone informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that she will retire from the Board effective December 31, 2026. Ms. Zarcone’s retirement is not the result of any disagreement with the Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CIGNA GROUP
Date: October 9, 2026
By:
/s/ Andrea Nelson
Andrea Nelson
Executive Vice President, General Counsel and Corporate Secretary
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 6, 2026
The Cigna Group
(Exact name of registrant as specified in its charter)
Delaware
001-38769
82-4991898
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
900 Cottage Grove Road
Bloomfield
,
Connecticut
06002
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(
860
)
226-6000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.01
CI
New York Stock Exchange, Inc.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 6, 2026, Donna F. Zarcone informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that she will retire from the Board effective December 31, 2026. Ms. Zarcone’s retirement is not the result of any disagreement with the Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CIGNA GROUP
Date: October 9, 2026
By:
/s/ Andrea Nelson
Andrea Nelson
Executive Vice President, General Counsel and Corporate Secretary
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
20ec531e54· 2026-10-11 09:12 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前